In an independant test study of 18 horse supplements, the prestigious Horse Journal named Recovery EQ "the best performer overall", describing Recovery EQ as "good for the tough case, not responding well to other products." Interestingly, Recovery EQ was the only supplement tested which had a 100% success rate. It pleased but did not surprise us to hear Horse Journal state "Recovery EQ was our favorite overall." Click here for a pdf file of the Horse Journal article.
How did the horses that were tested respond? Read the field trial results below...Recovery-EQ™
Field Trial Results
10 YO mare with chronic back pain necessitating
injections of Sarapin at acupuncture and trigger points for control every 4 to
6 weeks, arthritic hocks and one arthritic fetlock (front).
Glucosamine 10 g/day: 90% improvement in pain in joints, no change in back,
minimal change in joint effusion.
Glucosamine 20 g/day: There were no further changes.
Glucosamine 10 g/day with 10 g/day MSM: There was no change over glucosamine
alone. At 20g then 30g/day MSM there was still no change in back,
possible slight subjective improvement in joint effusion.
Recovery therapeutic dose: Pain in joints same as with glucosamine alone
(90% improvement), in addition, there was a 50% reduction in joint effusion at
3.5 weeks, marked reduction in back pain to the point that the next anticipated
injection time could be skipped.
3 YO colt in race training. OCD (osteochondrosis
dessicans) in one hock and knee synovitis.
Recovery therapeutic dose: There was resolution of synovitis by clinical findings in 2.5 weeks with no reduction in
work level. There was reduction in the lameness grade of the hock from 2+
to 1 in the same time period, with no effect on joint effusion.
Recovery maintenance dose: Held improvement for 2 weeks, then gradual
increase in hock lameness. Condition improved again on higher doses.
Synovitis did not recur.
3 YO colt in race training. Arthritis in the
knees and one front fetlock.
Glucosamine 10 g/day: There was an improvement in the lameness grade from
2.5/3.0 down to 1.5.
Glucosamine 20 g/day: There was no further improvement, no change with added
MSM at up to 30 grams/day.
Recovery therapeutic dose: Completely sound.
Recovery maintenance dose: Returned to lameness grade of 1.5 within 5 to 7 days,
again sound back on therapeutic dose.
3 YO filly in race training. Synovitis of
Glucosamine 10 g/day: Sound
Recovery therapeutic and maintenance doses: Sound
8 YO mare with suspected autoimmune
arthritis. Pasture sound but with persistent joint effusion in the knees
and one hind fetlock, would start to show lameness within 10 days of resuming
Glucosamine 10 g/day: Lameness was minimal with work (grade I) but present, with
no effect on joint effusion.
Glucosamine 20 to 25 g/day: There was no further change.
Addition of MSM at 10 to 25 g/day: There
was no further change at 10 grams, 50% reduction at 25 g/day.
Recovery therapeutic dose: Lameness minimal with work (grade I), 50%
reduction in joint effusion.
18 YO gelding. Polyarthritis and generalized
Glucosamine, chondroitin sulfate and MSM: There was moderate response when used
alone or in combination, but still stiff, sore and slow moving.
Recovery therapeutic dose: Marked improvement in attitude and reduction
in stiffness. Spontaneous trotting and
cantering were noted. Lameness grade in worst joint (hock) reduced to 1
Recovery maintenance dose: Held improvement.
2 YO gelding. Synovitis of the front fetlocks.
Recovery therapeutic dose: There was an 80% resolution at 2 weeks, 100%
resolution at 3 weeks. No interruption of training.
2 YO gelding.
Synovitis of the front fetlocks.
Recovery therapeutic dose: 100% resolution at 2 weeks. No interruption of
25 YO mare, extensive ringbone. Lameness
grade 2 to 3 at baseline on field turn out.
Glucosamine and glucosamine combined with MSM, up to 20 g/day each: There was
an improvement in overall stiffness, getting up and down easier; however, there
was no change in lameness related to the ringbone.
Recovery therapeutic dose: There was a marked improvement in attitude and
amount of moving around she did by 5 days. Lameness improved to
consistent grade 2 with no "bad days" during the trial period.
Recovery maintenance dose: Less spontaneous movement, more stiffness after a
week, improved again back on therapeutic dose.
In all cases there was no rest/reduction in exercise during the trial,
many with increased level of exercise as would normally occur during a training
program. There was no change in other supplements or diet, no drugs were administered,
no joint injections, no management changes in reference to hosing, icing,
bandaging, etc. that were not already in place at time of starting the trial.
Eleanor Kellon, D.V.M.